Sale!

Hemophilia A Carrier Detection Test Cost

Original price was: 2,720 د.إ.Current price is: 2,450 د.إ.

-10%

Hemophilia A is a genetic disorder characterized by a deficiency in the factor VIII clotting factor, leading to excessive bleeding. Carrier detection tests for Hemophilia A are crucial for identifying individuals who carry the defective gene, even if they do not exhibit symptoms of the disorder themselves. These carriers, often female, have a 50% chance of passing the gene to their offspring, making the detection vital for family planning and management of the condition.

DNA Labs UAE offers a comprehensive Hemophilia A Carrier Detection Test, aimed at identifying the presence of the genetic mutation associated with Hemophilia A. The test is conducted using advanced genetic analysis techniques to examine the specific gene known to cause the disorder. It provides families with the necessary information to understand their genetic risk and make informed decisions regarding their health and the health of future generations.

The cost of the Hemophilia A Carrier Detection Test at DNA Labs UAE is 2450 AED. The test is a valuable resource for those with a family history of Hemophilia A, offering peace of mind and the opportunity to seek early intervention and support if needed. With a commitment to accuracy and confidentiality, DNA Labs UAE ensures that individuals receive comprehensive counseling and support throughout the testing process.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

HEMOPHILIA A CARRIER DETECTION Test

At DNA Labs UAE, we offer the HEMOPHILIA A CARRIER DETECTION Test to determine if an individual carries the gene mutation for hemophilia A. Hemophilia A is a genetic bleeding disorder caused by a deficiency in clotting factor VIII.

Test Cost: AED 2450.0

Symptoms and Diagnosis

Carriers of the gene mutation for hemophilia A do not typically show symptoms of the disorder but can pass the gene mutation onto their children. The HEMOPHILIA A CARRIER DETECTION Test involves analyzing a blood sample to detect the presence of the gene mutation responsible for hemophilia A.

Test Components

  • Factor VIII
  • vWF Antigen
  • Factor VIII / vWF Ratio

Sample Condition

3 mL whole blood in 1 Blue Top (Sodium Citrate) tube. Mix thoroughly by inversion. Transport to Lab within 4 hours. If this is not possible, make PPP within 1 hour of collection as follows: Centrifuge sample at 3600 rpm for 15 min. & transfer supernatant to a clean plastic tube. Centrifuge this supernatant again at 3600 rpm for 15 mins. & finally transfer the supernatant (PPP) to 1 labelled, clean plastic screw capped vial. FREEZE IMMEDIATELY. Ship frozen. DO NOT THAW. Overnight fasting is preferred. Duly filled Coagulation Requisition Form (Form 15) is mandatory.

Report Delivery

Sample 1st & 3rd Mon by 11 am; Report Next day

Method

Electromechanical Clot Detection, EIA

Test Type

Disorders of Coagulation

Doctor

Hematologist

Test Department

Pre Test Information

Overnight fasting is preferred. Duly filled Coagulation Requisition Form (Form 15) is mandatory. It is recommended that the patient discontinues Heparin for 1 day and Oral Anticoagulants for 7 days prior to sampling as these drugs may affect test results. Discontinuation should be with the prior consent of the treating Physician.

Test Details

The Hemophilia A carrier detection test is a genetic test used to determine if an individual carries the gene mutation for hemophilia A. This test is usually performed on women who have a family history of hemophilia A or who are at risk of being carriers. The test involves analyzing a blood sample to detect the presence of the gene mutation responsible for hemophilia A.

If a woman is found to be a carrier, there is a 50% chance that she will pass the gene mutation onto her children. This information can help individuals make informed decisions about their reproductive options and medical management.

It is important to note that this test specifically detects the gene mutation for hemophilia A and not other types of hemophilia or bleeding disorders. If there is a suspicion of a different bleeding disorder, additional tests may be necessary.

Test Name HEMOPHILIA A CARRIER DETECTION Test
Components *Factor VIII*vWF Antigen*Factor VIII / vWF Ratio
Price 2450.0 AED
Sample Condition 3 mL whole blood in 1 Blue Top (Sodium Citrate) tube. Mix thoroughly by inversion. Transport to Lab within 4 hours. If this is not possible, make PPP within 1 hour of collection as follows: Centrifuge sample at 3600 rpm for 15 min. & transfer supernatant to a clean plastic tube. Centrifuge this supernatant again at 3600 rpm for 15 mins. & finally transfer the supernatant (PPP) to 1 labelled, clean plastic screw capped vial. FREEZE IMMEDIATELY. Ship frozen. DO NOT THAW. Overnight fasting is preferred. Duly filled Coagulation Requisition Form (Form 15)is mandatory.
Report Delivery Sample 1st & 3rd Mon by 11 am; Report Next day
Method Electromechanical Clot Detection, EIA
Test type Disorders of Coagulation
Doctor Hematologist
Test Department:
Pre Test Information Overnight fasting is preferred. Duly filled Coagulation Requisition Form (Form 15)is mandatory. It is recommended that patient discontinues Heparin for 1 day and Oral Anticoagulants for 7 days prior to sampling as these drugs may affect test results. Discontinuation should be with prior consent of treating Physician.
Test Details

Hemophilia A carrier detection test is a genetic test used to determine if an individual carries the gene mutation for hemophilia A. Hemophilia A is a genetic bleeding disorder caused by a deficiency in clotting factor VIII. Carriers of the gene mutation do not typically show symptoms of the disorder but can pass the gene mutation onto their children.

The test is usually performed on women who have a family history of hemophilia A or who are at risk of being carriers. It involves analyzing a blood sample to detect the presence of the gene mutation responsible for hemophilia A.

The test can provide important information for family planning and genetic counseling. If a woman is found to be a carrier, there is a 50% chance that she will pass the gene mutation onto her children. This information can help individuals make informed decisions about their reproductive options and medical management.

It is important to note that this test specifically detects the gene mutation for hemophilia A and not other types of hemophilia or bleeding disorders. If there is a suspicion of a different bleeding disorder, additional tests may be necessary.